The MEK1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma

Mikhail Chesnokov, Imran Khan, Yeonjung Park, Jessica Ezel, Geeta Mehta, Abdelrahman Yousif, Linda J. Hong, Ronald J. Buckanovich, Ronald J. Buckanovich, Ilana Chefetz, Ilana Chefetz

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalbioRxiv
DOIs
StatePublished - Sep 16 2019

Disciplines

  • Biology
  • Oncology
  • Bioinformatics

Cite this